Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37 | 0 | 4 | 82 | 167 |
| TOTAL | $54 | $13 | $18 | $101 | $200 |
| Non-Current Assets | |||||
| PPE Net | 13 | 29 | 45 | 61 | 77 |
| TOTAL | $13 | $29 | $45 | $61 | $77 |
| Total Assets | $67 | $42 | $63 | $162 | $277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,864 | 1,897 | 1,867 | 1,858 | 1,828 |
| Accrued Expenses | 3,350 | 3,237 | 3,042 | 2,857 | 2,677 |
| Other current liabilities | 749 | 779 | 780 | 825 | 883 |
| TOTAL | $6,230 | $6,175 | $5,945 | $5,791 | $5,634 |
| Non-Current Liabilities | |||||
| Long Term Debt | 120 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 2 | 5 | 8 | 10 | 13 |
| Other Non-Current Liabilities | 20 | 25 | 27 | 207 | -32 |
| TOTAL | $120 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,351 | $6,175 | $5,945 | $5,791 | $5,634 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,489 | 14,489 | 14,489 | N/A | 14,434 |
| Common Shares | 601 | 601 | 601 | 601 | 601 |
| Retained earnings | -120,362 | -120,232 | -120,005 | -119,779 | -119,537 |
| Other shareholders' equity | -543 | -524 | -499 | -472 | -443 |
| TOTAL | $-6,284 | $-6,133 | $-5,882 | $-5,629 | $-5,358 |
| Total Liabilities And Equity | $67 | $42 | $63 | $162 | $276 |